Aarhus Universitets segl

Kenneth Brandt Hansen

Sparsom evidens for antipsykotika til behandling af organisk delirium

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

Traditionally, haloperidol has been the recommended antipsychotic drug for pharmacological treatment of delirium, which is a frequent complication in the critical care setting. Due to a less frequent occurrence of extrapyramidal adverse effects, second-generation antipsychotic drugs have been evaluated. In the present paper we review the current randomized prospective studies of second-generation antipsychotics as treatment for delirium in hospitalized patients and conclude that so far the evidence in favour of these drugs compared with haloperidol is still sparse.

Bidragets oversatte titelSparse evidence of antipsychotic drugs for the treatment of delirium
TidsskriftUgeskrift for Laeger
Sider (fra-til)1858-1862
StatusUdgivet - 14 apr. 2014


  • Amisulpride, Antipsychotic Agents/therapeutic use, Benzodiazepines/therapeutic use, Delirium/drug therapy, Evidence-Based Medicine, Humans, Olanzapine, Piperazines/therapeutic use, Quetiapine Fumarate/therapeutic use, Risperidone/therapeutic use, Sulpiride/analogs & derivatives, Thiazoles/therapeutic use

Se relationer på Aarhus Universitet Citationsformater

ID: 139719880